Safe Treatments and Opportunities to Prevent Pain Act

1/11/2023, 1:31 PM

Congressional Summary of S 2678

Safe Treatments and Opportunities to Prevent Pain Act or the STOP Pain Act

This bill authorizes the National Institutes of Health (NIH) to intensify and coordinate NIH research into the understanding of pain, therapies for chronic pain, and alternatives to opioids (drugs with effects similar to opium) for pain treatments.

The prioritization and direction of federally funded pain research must consider recommendations made by the Interagency Pain Research Coordinating Committee.

Current Status of Bill S 2678

Bill S 2678 is currently in the status of Bill Introduced since March 15, 2016. Bill S 2678 was introduced during Congress 114 and was introduced to the Senate on March 15, 2016.  Bill S 2678's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 15, 2016

Bipartisan Support of Bill S 2678

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
5
Democrat Cosponsors
2
Republican Cosponsors
3
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 2678

Primary Policy Focus

Health

Potential Impact Areas

Drug therapyDrug trafficking and controlled substancesMedical researchPrescription drugsResearch administration and funding

Alternate Title(s) of Bill S 2678

Safe Treatments and Opportunities to Prevent Pain ActA bill to direct the NIH to intensify and coordinate fundamental, translational, and clinical research with respect to the understanding of pain, the discovery and development of therapies for chronic pain, and the development of alternatives to opioids for effective pain treatments.Safe Treatments and Opportunities to Prevent Pain ActSTOP Pain Act
Start holding our government accountable!

Comments